Literature DB >> 19140224

Diet and epigenetics in colon cancer.

Minna Nystrom, Marja Mutanen.   

Abstract

Over the past few years, evidence has accumulated indicating that apart from genetic alterations, epigenetic alterations, through e.g. aberrant promoter methylation, play a major role in the initiation and progression of colorectal cancer (CRC). Even in the hereditary colon cancer syndromes, in which the susceptibility is inherited dominantly, cancer develops only as the result of the progressive accumulation of genetic and epigenetic alterations. Diet can both prevent and induce colon carcinogenesis, for instance, through epigenetic changes, which regulate the homeostasis of the intestinal mucosa. Food-derived compounds are constantly present in the intestine and may shift cellular balance toward harmful outcomes, such as increased susceptibility to mutations. There is strong evidence that a major component of cancer risk may involve epigenetic changes in normal cells that increase the probability of cancer after genetic mutation. The recognition of epigenetic changes as a driving force in colorectal neoplasia would open new areas of research in disease epidemiology, risk assessment, and treatment, especially in mutation carriers who already have an inherited predisposition to cancer.

Entities:  

Mesh:

Year:  2009        PMID: 19140224      PMCID: PMC2653321          DOI: 10.3748/wjg.15.257

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  73 in total

1.  Maternal epigenetics and methyl supplements affect agouti gene expression in Avy/a mice.

Authors:  G L Wolff; R L Kodell; S R Moore; C A Cooney
Journal:  FASEB J       Date:  1998-08       Impact factor: 5.191

2.  Epigenetic phenotypes distinguish microsatellite-stable and -unstable colorectal cancers.

Authors:  S A Kuismanen; M T Holmberg; R Salovaara; P Schweizer; L A Aaltonen; A de La Chapelle; M Nyström-Lahti; P Peltomäki
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

Review 3.  Epidemiology of colorectal cancer.

Authors:  Peter Boyle; Maria Elena Leon
Journal:  Br Med Bull       Date:  2002       Impact factor: 4.291

4.  CpG island methylator phenotype in colorectal cancer.

Authors:  M Toyota; N Ahuja; M Ohe-Toyota; J G Herman; S B Baylin; J P Issa
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

5.  CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies.

Authors:  S Ogino; M Cantor; T Kawasaki; M Brahmandam; G J Kirkner; D J Weisenberger; M Campan; P W Laird; M Loda; C S Fuchs
Journal:  Gut       Date:  2006-01-11       Impact factor: 23.059

6.  Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4.

Authors:  V Korinek; N Barker; P Moerer; E van Donselaar; G Huls; P J Peters; H Clevers
Journal:  Nat Genet       Date:  1998-08       Impact factor: 38.330

7.  Fetal programming of colon cancer in adult rats: correlations with altered neonatal growth trajectory, circulating IGF-I and IGF binding proteins, and testosterone.

Authors:  Rijin Xiao; Leah J Hennings; Thomas M Badger; Frank A Simmen
Journal:  J Endocrinol       Date:  2007-10       Impact factor: 4.286

8.  Cancer survival in five continents: a worldwide population-based study (CONCORD).

Authors:  Michel P Coleman; Manuela Quaresma; Franco Berrino; Jean-Michel Lutz; Roberta De Angelis; Riccardo Capocaccia; Paolo Baili; Bernard Rachet; Gemma Gatta; Timo Hakulinen; Andrea Micheli; Milena Sant; Hannah K Weir; J Mark Elwood; Hideaki Tsukuma; Sergio Koifman; Gulnar Azevedo E Silva; Silvia Francisci; Mariano Santaquilani; Arduino Verdecchia; Hans H Storm; John L Young
Journal:  Lancet Oncol       Date:  2008-07-17       Impact factor: 41.316

9.  Dietary calcium and cholecalciferol modulate cyclin D1 expression, apoptosis, and tumorigenesis in intestine of adenomatous polyposis coli1638N/+ mice.

Authors:  Kan Yang; Sergio A Lamprecht; Hiroharu Shinozaki; Kunhua Fan; Wancai Yang; Harold L Newmark; Levy Kopelovich; Winfried Edelmann; Bo Jin; Claudia Gravaghi; Leonard Augenlicht; Raju Kucherlapati; Martin Lipkin
Journal:  J Nutr       Date:  2008-09       Impact factor: 4.798

10.  Global transcript profiles of fat in monozygotic twins discordant for BMI: pathways behind acquired obesity.

Authors:  Kirsi H Pietiläinen; Jussi Naukkarinen; Aila Rissanen; Juha Saharinen; Pekka Ellonen; Heli Keränen; Anu Suomalainen; Alexandra Götz; Tapani Suortti; Hannele Yki-Järvinen; Matej Oresic; Jaakko Kaprio; Leena Peltonen
Journal:  PLoS Med       Date:  2008-03-11       Impact factor: 11.069

View more
  19 in total

1.  Differential clinicopathological features in microsatellite instability-positive colorectal cancers depending on CIMP status.

Authors:  Jeong Mo Bae; Mi Jung Kim; Jung Ho Kim; Jae Moon Koh; Nam-Yun Cho; Tae-You Kim; Gyeong Hoon Kang
Journal:  Virchows Arch       Date:  2011-04-15       Impact factor: 4.064

Review 2.  The Enigmatic Gut in Cystic Fibrosis: Linking Inflammation, Dysbiosis, and the Increased Risk of Malignancy.

Authors:  Millie Garg; Chee Y Ooi
Journal:  Curr Gastroenterol Rep       Date:  2017-02

3.  Healthy dietary patterns and risk and survival of breast cancer: a meta-analysis of cohort studies.

Authors:  Ruixue Hou; Jingkai Wei; Yirui Hu; Xiaotao Zhang; Xuezheng Sun; Eeshwar K Chandrasekar; Venkata Saroja Voruganti
Journal:  Cancer Causes Control       Date:  2019-06-05       Impact factor: 2.506

4.  Beliefs about cancer and diet among those considering genetic testing for colon cancer.

Authors:  Aunchalee E L Palmquist; Rachel Upton; Seungjin Lee; Abby T Panter; Don W Hadley; Laura M Koehly
Journal:  J Nutr Educ Behav       Date:  2011-02-05       Impact factor: 3.045

Review 5.  Opportunities and challenges for selected emerging technologies in cancer epidemiology: mitochondrial, epigenomic, metabolomic, and telomerase profiling.

Authors:  Mukesh Verma; Muin J Khoury; John P A Ioannidis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-12-14       Impact factor: 4.254

Review 6.  Toxicogenomics and cancer susceptibility: advances with next-generation sequencing.

Authors:  Baitang Ning; Zhenqiang Su; Nan Mei; Huixiao Hong; Helen Deng; Leming Shi; James C Fuscoe; William H Tolleson
Journal:  J Environ Sci Health C Environ Carcinog Ecotoxicol Rev       Date:  2014       Impact factor: 3.781

7.  Association among resistin, adenylate cyclase-associated protein 1 and high-density lipoprotein cholesterol in patients with colorectal cancer: a multi-marker approach, as a hallmark of innovative predictive, preventive, and personalized medicine.

Authors:  Marija Mihajlovic; Ana Ninic; Miron Sopic; Milica Miljkovic; Aleksandra Stefanovic; Jelena Vekic; Vesna Spasojevic-Kalimanovska; Dejan Zeljkovic; Bratislav Trifunovic; Zeljka Stjepanovic; Aleksandra Zeljkovic
Journal:  EPMA J       Date:  2019-07-20       Impact factor: 6.543

Review 8.  Modulation of epigenetic targets for anticancer therapy: clinicopathological relevance, structural data and drug discovery perspectives.

Authors:  Federico Andreoli; Arménio Jorge Moura Barbosa; Marco Daniele Parenti; Alberto Del Rio
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.310

Review 9.  Genetics, cytogenetics, and epigenetics of colorectal cancer.

Authors:  Lucia Migliore; Francesca Migheli; Roberto Spisni; Fabio Coppedè
Journal:  J Biomed Biotechnol       Date:  2011-02-14

10.  Acrolein contributes to human colorectal tumorigenesis through the activation of RAS-MAPK pathway.

Authors:  Hong-Chieh Tsai; Han-Hsing Tsou; Chun-Chi Lin; Shao-Chen Chen; Hsiao-Wei Cheng; Tsung-Yun Liu; Wei-Shone Chen; Jeng-Kai Jiang; Shung-Haur Yang; Shih-Ching Chang; Hao-Wei Teng; Hsiang-Tsui Wang
Journal:  Sci Rep       Date:  2021-06-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.